Growth Metrics

Rigel Pharmaceuticals (RIGL) Inventory Average (2018 - 2025)

Rigel Pharmaceuticals has reported Inventory Average over the past 8 years, most recently at $12.4 million for Q4 2025.

  • Quarterly results put Inventory Average at $12.4 million for Q4 2025, up 130.01% from a year ago — trailing twelve months through Dec 2025 was $12.4 million (up 130.01% YoY), and the annual figure for FY2025 was $8.8 million, up 51.93%.
  • Inventory Average for Q4 2025 was $12.4 million at Rigel Pharmaceuticals, up from $11.9 million in the prior quarter.
  • Over the last five years, Inventory Average for RIGL hit a ceiling of $12.4 million in Q4 2025 and a floor of $4.3 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $6.9 million (2021), compared with a mean of $7.5 million.
  • Biggest five-year swings in Inventory Average: soared 316.82% in 2021 and later crashed 40.08% in 2024.
  • Rigel Pharmaceuticals' Inventory Average stood at $6.8 million in 2021, then grew by 18.92% to $8.1 million in 2022, then decreased by 28.34% to $5.8 million in 2023, then fell by 7.29% to $5.4 million in 2024, then soared by 130.01% to $12.4 million in 2025.
  • The last three reported values for Inventory Average were $12.4 million (Q4 2025), $11.9 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.